Your one stop place for all the latest ReGen Factor news and updates on progress with product developments, FDA trials, ASX listing, Industry News and Scientific Studies.
Press Release: ReGen Factor Announces New PET NMN Supplement for Dogs and Cats 25 July 2024 Sydney, Australia – ReGen Factor, a leading innovator in
Report to Dr. Jones 15 July 2024 Basic fibroblast growth factor (bFGF) can be applied to the fallopian tubes as a therapeutic agent aimed at
Age Reversal Breakthrough Scientists from Harvard Medical School, the University of Maine, and MIT have published a groundbreaking study revealing a chemical method to reprogram
Report to Dr. Jones Basic Fibroblast Growth Factor (bFGF) in Infertility Treatment: A Comprehensive Review Introduction Infertility affects a significant portion of the global
NMN and Exosome Research in Veterinary Applications 25 June 2024 Sydney, Australia by Claire Ironside Abstract This paper explores the implications of Nicotinamide Mononucleotide (NMN)
Welcome to ReGen Factor’s latest quarterly update. Since our last update in May 2022, we have made significant strides towards achieving our goals. This update
Prioritizing FDA applications for diabetic ulcers and diabetic retinopathy using their recombinant human basic Fibroblast Growth Factor (rh bFGF). This shift addresses substantial unmet medical
NEWS PROVIDED BY ReGen Factor Pty Ltd August 02, 2022, 22:01 GMT SHARE THIS ARTICLE ReGen Factor and MedSpa Equip UK have partnered to expand
